MOLECULAR IMAGING MARKET ANALYSIS
Among regions, North America is estimated to hold a dominant position in the global molecular imaging market over the forecast period. North America is estimated to hold 33.5 % of the market share in 2023. The global molecular imaging market is expected to witness significant growth in the coming years, due to increasing inorganic growth strategies, such as acquisitions by key market players. For instance, on February 6, 2023, Lantheus, a U.S.-based manufacturer of medical imaging products, announced it had acquired Cerveau Technologies, Inc. a U.S. based medical technology company. Cerveau’s asset is MK-6240, a second-generation F 18-labeled positron emission tomography (“PET”) imaging agent that targets Tau tangles in Alzheimer’s disease.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowPress Release
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
